본문 바로가기
KERD
논문KCI 등재

Risk Factors for the Presence of Symptoms in Peptic Ulcer Disease

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류내과학

초록

Background/Aims: Peptic ulcer disease (PUD) is a common condition, but is difficult to detect in asymptomatic individuals. We aimed to investigate the prevalence of symptomatic and asymptomatic PUD during screening endoscopy and to identify risk factors for the presence of symptoms in patients with PUD. Methods: We investigated subjects who underwent a health inspection, including endoscopy of the upper gastrointestinal (GI) tract and a serum anti-Helicobacter pylori IgG assay, and who completed a self-report questionnaire about their symptoms. Results: Of the 12,852 subjects included in the study, 124 (1.0%) had symptomatic PUD and 309 (2.4%) had asymptomatic PUD. Old age, current smoking, and H. pylori infection were independent risk factors for symptomatic and asymptomatic PUD. Use of non-steroidal anti-inflammatory drugs (NSAIDs) was an independent risk factor only for symptomatic PUD (p=0.040). Compared to subjects with asymptomatic PUD, subjects with symptomatic PUD were more likely to have active-stage ulcers (p=0.002) and to drink more heavily (p=0.005). Conclusions: Use of NSAIDs is a risk factor for symptomatic PUD, but not for asymptomatic PUD. Excessive alcohol consumption and active-stage ulcers in patients with PUD are related to the presence of gastroduodenal symptoms.

Abstract

Background/Aims: Peptic ulcer disease (PUD) is a common condition, but is difficult to detect in asymptomatic individuals. We aimed to investigate the prevalence of symptomatic and asymptomatic PUD during screening endoscopy and to identify risk factors for the presence of symptoms in patients with PUD. Methods: We investigated subjects who underwent a health inspection, including endoscopy of the upper gastrointestinal (GI) tract and a serum anti-Helicobacter pylori IgG assay, and who completed a self-report questionnaire about their symptoms. Results: Of the 12,852 subjects included in the study, 124 (1.0%) had symptomatic PUD and 309 (2.4%) had asymptomatic PUD. Old age, current smoking, and H. pylori infection were independent risk factors for symptomatic and asymptomatic PUD. Use of non-steroidal anti-inflammatory drugs (NSAIDs) was an independent risk factor only for symptomatic PUD (p=0.040). Compared to subjects with asymptomatic PUD, subjects with symptomatic PUD were more likely to have active-stage ulcers (p=0.002) and to drink more heavily (p=0.005). Conclusions: Use of NSAIDs is a risk factor for symptomatic PUD, but not for asymptomatic PUD. Excessive alcohol consumption and active-stage ulcers in patients with PUD are related to the presence of gastroduodenal symptoms.

참고문헌 (24)

  1. Milosavljevic T, "Complications of peptic ulcer disease", Dig Dis, 29, pp.491~493 (2011)
  2. Al Dhahab H, "State-of-the-art management of acute bleeding peptic ulcer disease", Saudi J Gastroenterol, 19, pp.195~204 (2013)
  3. Wolfe MM, "Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs", N Engl J Med, 340, pp.1888~1899 (1999)
  4. Hopkins RJ, "Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review", Gastroenterology, 110, pp.1244~1252 (1996)
  5. Atherton JC, "Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration", J Biol Chem, 270, pp.17771~17777 (1995)
  6. Hunt RH, "Acid-NSAID", aspirin interaction in peptic ulcer disease, 2011, pp.29, 465~468
  7. Yamaoka Y, "Helicobacter pylori outer membrane proteins and gastroduodenal disease", Gut, 55, pp.775~781 (2006)
  8. Potamitis GS, "Helicobacter pylori and Nonmalignant Diseases", Helicobacter, 20(Suppl 1), pp.26~29 (2015)
  9. Thorat MA, "Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population", Eur J Epidemiol, 30, pp.5~18 (2015)
  10. Sasaki H, "Ten-year trend of the cumulative Helicobacter pylori eradication rate for the ‘Japanese eradication strategy’", Digestion, 88, pp.272~278 (2013)
  11. Kim JH, "Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea", J Gastroenterol Hepatol, 16, pp.969~975 (2001)
  12. Lau JY, "Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality", Digestion, 84, pp.102~113 (2011)
  13. Choi HS, "Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm", J Dig Dis, 15, pp.293~298 (2014)
  14. Halder SL, "Influence of alcohol consumption on IBS and dyspepsia", Neurogastroenterol Motil, 18, pp.1001~1008 (2006)
  15. Kim HM, "NSAID is inversely associated with asymptomatic gastric ulcer: local health examination data from the Korean National Health Insurance Corporation", Scand J Gastroenterol, 48, pp.1371~1376 (2013)
  16. Yap PR, "Non-steroidal anti-inflammatory drugs (NSAIDs)induced dyspepsia", Curr Pharm Des, 21, pp.5073~5081 (2015)
  17. D’Elios MM, "Inflammation, immunity, and vaccines for Helicobacter pylori", Helicobacter, 14(Suppl 1), pp.21~28 (2009)
  18. Tahara T, "Association of endoscopic appearances with dyspeptic symptoms", J Gastroenterol, 43, pp.208~215 (2008)
  19. Li LF, "Cigarette smoking and gastrointestinal diseases:the causal relationship and underlying molecular mechanisms", Int J Mol Med, 34, pp.372~380 (2014)
  20. 이상표, "The Effect of Emotional Stress and Depression on the Prevalence of Digestive Diseases", Journal of Neurogastroenterology and Motility (JNM), 21(2), pp.273~282 (2015), 대한소화기 기능성질환∙운동학회[DOI]
  21. Ford AC, "Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria", Aliment Pharmacol Ther, 39, pp.312~321 (2014)
  22. Tadayuki Oshima, "Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World", Journal of Neurogastroenterology and Motility (JNM), 21(3), pp.320~329 (2015), 대한소화기 기능성질환∙운동학회[DOI]
  23. Bode G, "Dyspeptic symptoms in middle-aged to old adults: the role of Helicobacter pylori infection, and various demographic and lifestyle factors", J Intern Med, 252, pp.41~47 (2002)
  24. Stone MA, "Lack of correlation between self-reported symptoms of dyspepsia and infection with Helicobacter pylori, in a general population sample", Eur J Gastroenterol Hepatol, 10, pp.301~304 (1998)

관련 논문AI추천

High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up윤혁, 김상균, 송인성, 정현채거트앤리버 소화기연관학회협의회 · Gut and Liver2013 · 제7권 제2호Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori김병욱, 김상균, 김성수, 김지현, 김진일, 백광호, 심기남, 정우철, 홍수진, Jae Hyun Seo, Sam Ryong Jee거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제5호Helicobacter pylori Infection and Peptic Ulcer Disease In Patients with Liver Cirrhosis김동준, 김진봉, 김학양, 박상훈, 박충기, 백광호, 장명국, Myung-Seok Lee, Sung Jung Kim, Tae Ho Hahn대한내과학회 · The Korean Journal of Internal Medicine2008 · 제23권 제1호Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control StudyHiromitsu Kanzaki, Hiroyuki Okada, Kazuhide Yamamoto, Keisuke Hori, Ko Miura, Masahide Kita, Ryuta Takenaka, Seiji Kawano, Takao Tsuzuki, Yoshiro Kawahara, Yoshiyasu Kono거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호Characteristics of Hemorrhagic Peptic Ulcers in Patients Receiving Antithrombotic/Nonsteroidal Antiinflammatory Drug TherapyEikichi Ihara, Haruei Ogino, Hirotada Akiho, Kana Kakigao, Kazuhiko Nakamura, Kazuhiro Haraguchi, Kazuya Akahoshi, Keishi Komori, Munehiro Tanaka, Naohiko Harada, Norimoto Nakamura, Ryoichi Takayanagi, Teppei Kabemura, Tetsuhide Ito, Toshiaki Ochiai, Yasuaki Motomura, Yoshiharu Chijiiwa, Yoshimasa Tanaka거트앤리버 소화기연관학회협의회 · Gut and Liver2012 · 제6권 제4호A systematic approach for the diagnosis and treatment of idiopathic peptic ulcersChen-Shuan Chung, Tsung-Hsien Chiang, Yi-Chia Lee대한내과학회 · The Korean Journal of Internal Medicine2015 · 제30권 제5호

이 간행물의 다른 논문 (7건)